Expertise

Aumapharma brings versatile, in-depth experience in the areas of pulmonary drug development, with a particular focus on Cystic Fibrosis, Asthma, COPD and Pulmonary Fibrosis. In addition, Aumapharma possesses expertise in the area of Intensive Care, Neonatology, and Antiinfectives.

Aumapharma has extensive expertise in aerosolized products, and has been involved with successful drug developments in the US (FDA), as well as in Europe (EMEA, BfArM).